lung neoplasms

Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study
Silvia Bessi, Francesco Pepe, Gianluca Russo, Pasquale Pisapia, Marco Ottaviantonio, Francesca Biancalani, Antonino Iaccarino, Maria Russo, Mauro Biancalani, Giancarlo Troncone, Umberto Malapelle

Journal of Clinical Pathology Mar 2023, 76 (3) 206-210; DOI: 10.1136/jclinpath-2022-208308
Primary salivary duct carcinoma of the lung: clinicopathological features, diagnosis and practical challenges
Shaoling Li, Likun Hou, Yan Huang, Wei Wu, Chunyan Wu, Liping Zhang

Journal of Clinical Pathology Jan 2023, jcp-2022-208671; DOI: 10.1136/jcp-2022-208671
Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions
John R Gosney, Michael D Peake, Keith M Kerr

Journal of Clinical Pathology Jan 2023, jcp-2022-208643; DOI: 10.1136/jcp-2022-208643
Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma
Fumi Okada, Maiko Takeda, Tomomi Fujii, Tomoko Uchiyama, Shoh Sasaki, Minami Matsuoka, Yuji Nitta, Chiyoko Terada, Katsuya Maebo, Kohei Morita, Eiwa Ishida, Noriyoshi Sawabata, Chiho Ohbayashi

Journal of Clinical Pathology Dec 2022, jcp-2022-208583; DOI: 10.1136/jcp-2022-208583
Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
Ea Maria Tønning Tønnesen, Magnus Stougaard, Peter Meldgaard, Johanne Lade-Keller

Journal of Clinical Pathology Nov 2022, jcp-2022-208574; DOI: 10.1136/jcp-2022-208574
Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available
Cristiana Ercolani, Anna Di Benedetto, Claudia Bonomo, Paolo Visca, Aldo Palange, Daniela Assisi, Daniele Forcella, Irene Terrenato, Edoardo Pescarmona, Gennaro Ciliberto, Fabiana Letizia Cecere, Federico Cappuzzo, Simonetta Buglioni

Journal of Clinical Pathology Dec 2022, 75 (12) 844-850; DOI: 10.1136/jclinpath-2021-207726
Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy
Erin Faber, Horiana Grosu, Sharjeel Sabir, Francis Anthony San Lucas, Bedia A Barkoh, Roland L Bassett, Rajyalakshmi Luthra, John Stewart, Sinchita Roy-Chowdhuri

Journal of Clinical Pathology Sep 2022, 75 (9) 612-619; DOI: 10.1136/jclinpath-2021-207597
Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients
Emmanuel Khalifa, Caroline Chapusot, Benjamin Tournier, Julie Sentis, Estelle Marion, Alicia Remond, Manon Aubry, Célia Pioche, Anthony Bergeron, Charlotte Primois, Larry Blanchard, Alice Millière, Marlène Boucheix, Yannick Léger, Marine Bairrao, Véronique Brouste, Laurent Martin, Isabelle Soubeyran

Journal of Clinical Pathology Jul 2022, jclinpath-2022-208325; DOI: 10.1136/jcp-2022-208325
Validation of multiplex immunofluorescence and digital image analysis for programmed death-ligand 1 expression and immune cell assessment in non-small cell lung cancer: comparison with conventional immunohistochemistry
Jianghua Wu, Luning Mao, Wei Sun, Xin Yang, Haiyue Wang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Dongmei Lin

Journal of Clinical Pathology Jul 2022, 75 (7) 452-458; DOI: 10.1136/jclinpath-2021-207448
Expression of programmed death-ligand 1 protein in pulmonary squamous cell carcinoma correlates with tumour necrosis but not with tumour differentiation
Vladimír Tancoš, Anna Farkašová, Zuzana Kviatkovská, Marián Grendár, Alena Líšková, Zdenko Huťka, Lukáš Plank

Journal of Clinical Pathology Jun 2022, 75 (6) 373-378; DOI: 10.1136/jclinpath-2020-207171

Main menu

lung neoplasms

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

lung neoplasms

Pages